| Sep 13, 2011
| 4:41 AM
LONDON (Reuters) - The number of people living with diabetes has soared to 366 million, and the disease kills one person every seven seconds, posing a "massive challenge" to healthcare systems worldwide, experts said on Tuesday.
The vast majority of...
| Feb 28, 2012
| 5:13 PM
A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...
| Nov 13, 2012
| 11:03 PM
LONDON (Reuters) - Diabetes is running at record levels worldwide and half the people estimated to have the disease are, as yet, undiagnosed, according to a report on Wednesday.
The number of people living with diabetes is now put at 371 million, up from...
| Nov 29, 2011
The nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4...
| Mar 30, 2009
Lost jobs and lost careers. Promising businesses in shambles. The college acceptance letter returned to its envelope. This is how President Obama recently described the effect of the tanking economy on ordinary Americans -- and the stresses keeping them...
| Dec 14, 2009
When your doctor writes you a prescription, that's just between you, your doctor and maybe your health insurance company -- right?
Wrong. As things stand now, the pharmaceutical companies that make those prescription drugs are looking over the doctor's...
| Jan 18, 2010
In a quest to look younger, be healthier and feel more vital later in life, increasing numbers of men, just like Jeffry Life, are turning to testosterone and human growth hormone. Use of both hormones is controversial. Read on:
Testosterone: "Older men ....
| Sep 15, 2010
There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny.
A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...
| Jun 17, 2010
A pink pill designed to boost sex drive in women - the latest attempt by the drug industry to find a female equivalent to Viagra - fell short in two studies, federal health regulators said Wednesday.
The Food and Drug Administration is considering...